Is IMNM or IMRX more undervalued in 2026?

CirclFi compares Immunome, Inc. (IMNM) and Immuneering Corporation (IMRX) using 13 institutional-grade valuation models. IMNM has a Quality of Company score of 5.0/10 while IMRX scores 4.5/10.

Which is a better buy — IMNM or IMRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IMNM and IMRX valuations compare?

IMNM at $22.54 and IMRX at $5.06 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IMNM vs IMRX Valuation Comparison 2026 — Intrinsic Value Analysis

IMNM

Biotechnology

Immunome, Inc.

Quality

5.0

out of 10

Value Trap

SAFE

Price

$22.54

Last close

Models

12/13

Active

IMRX

Biotechnology

Immuneering Corporation

Quality

4.5

out of 10

Value Trap

LOW

Price

$5.06

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	IMNM Fair Value	IMNM Upside	IMRX Fair Value	IMRX Upside
Bayesian DCF	Intrinsic	$5.22	-76.8%	$1.74	-65.7%
Earnings Power Value	Intrinsic	$3.35	-85.3%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.20	-86.0%	$1.66	-67.2%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMNM vs IMRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMNM vs IMRX — Which Stock Is More Undervalued?

IMNM scores higher with a 5.0/10 quality rating vs IMRX's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Immunome, Inc. (IMNM) and Immuneering Corporation (IMRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMNM currently trades at $22.54 with a QOC of 5.0/10, while IMRX trades at $5.06 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).